Today's health developments span gender equity in healthcare systems, advances in rare disease treatments, obesity drug positioning updates, antimicrobial resistance awareness, and emerging safety concerns in endocrinology and cardiology.

Scotland's health system exhibits systemic gender inequalities leaving many patients unseen and unsupported, according to a new Voluntary Health Scotland report highlighting widespread misogyny affecting patient care quality.

Treprostinil demonstrated even stronger efficacy in the TETON-1 phase 3 trial for idiopathic pulmonary fibrosis (IPF) compared to the TETON-2 study, marking a significant advancement in treatment options for this serious lung condition.

The European Association for the Study of Obesity updated its 'living' algorithm, strengthening tirzepatide's position as a preferred weight-loss agent while reinforcing semaglutide's role in improving liver fibrosis in obesity patients.

Real physicians performed in the London stage production of 'Lifeline the Musical' to elevate public awareness about the growing threat of antimicrobial resistance, bringing the critical AMR crisis to broader audiences through theatrical engagement.

Research reveals that menopausal symptoms may be linked to reduced sexual satisfaction, emphasizing the need for clinicians to actively discuss sexual health and activity with menopausal and postmenopausal patients.

French regulators fined Novo Nordisk and Eli Lilly over their obesity awareness campaigns, citing concerns that public education efforts may inappropriately blur the line into prescription drug promotion.

Addition of liothyronine to levothyroxine treatment is associated with higher psychiatric morbidity risk in patients with autoimmune hypothyroidism, raising safety concerns about combination thyroid hormone therapy.

Adults with obesity may retain increased heart failure risk despite having natriuretic peptide levels below standard rule-out thresholds, suggesting current diagnostic criteria may miss high-risk patients in this population.